研究发现,糖尿病药物Canagliflozin可能通过增加氧气来保护肾脏。 Study finds diabetes drug canagliflozin may protect kidneys by enhancing oxygenation.

大阪大都会大学的研究人员发现,用于治疗糖尿病的SGLT2抑制剂也可能通过改善氧气来保护肾脏健康。 Researchers at Osaka Metropolitan University found that SGLT2 inhibitors, drugs used to manage diabetes, may also protect kidney health by improving oxygenation. 研究药物卡纳格里弗洛辛, 他们观察到使用非侵入性MRI技术改善脏氧水平. Studying the drug canagliflozin, they observed improved kidney oxygen levels using a non-invasive MRI technique. 这有助于预防与糖尿病有关的肾病,这一疾病预计到2030年将影响到1.91亿人。 This could help prevent kidney disease linked to diabetes, a condition expected to affect 191 million people by 2030.